Healthcare Co., Ltd.

SSE:603313.SS

8 (CNY) • At close May 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Revenue 2,042.8022,323.6882,179.022,127.7111,818.9682,260.4552,114.8291,901.8551,698.7771,949.3081,984.8881,939.7372,143.3132,028.7872,210.4692,010.9941,889.0042,003.782,110.3341,357.8971,058.1241,192.8081,058.579793.079787.122945.103821.38671.771611.22679.787615.636561.913481.468502.015446.005405.227369.787393.009346.27
Cost of Revenue 1,238.6031,490.5631,403.0261,323.7911,118.2171,288.7941,325.3891,215.4821,087.1711,259.5241,369.8951,382.4551,516.7041,446.4341,582.651,449.9971,342.971,651.661,201.542802.787659.401647.445672.935470.445518.824600.061552.64459.401459.018498.588437.515387.64324.207337.537294.468281.757230.306249.693215.148
Gross Profit 804.199833.125775.994803.921700.751971.661789.44686.373611.607689.783614.992557.282626.609582.353627.819560.997546.035352.12908.792555.11398.723545.363385.644322.634268.299345.042268.74212.37152.202181.199178.12174.273157.261164.479151.536123.47139.481143.316131.122
Gross Profit Ratio 0.3940.3590.3560.3780.3850.430.3730.3610.360.3540.310.2870.2920.2870.2840.2790.2890.1760.4310.4090.3770.4570.3640.4070.3410.3650.3270.3160.2490.2670.2890.310.3270.3280.340.3050.3770.3650.379
Reseach & Development Expenses 32.73543.87541.213323.42233.35735.34326.33820.6220.52824.80322.96127.01730.29133.69729.80330.45731.06537.62922.98318.47933.79728.75719.49719.17925.86524.78121.01917.388105.66620.49734.106052.913020.943043.8860
General & Administrative Expenses 121.683-168.127286.078-29.028126.339-162.084296.724-16.919124.976-197.611327.058-32.829154.861-191.149360.481-15.595150.118-48.989116.96519.72365.694-39.14847.9246.18145.422-29.74238.065-23.50551.485-80.70750.921-19.21943.863-57.74733.858-16.73432.365-46.50827.562
Selling & Marketing Expenses 512.7148.183753.623477.377444.249538.56449.265409.677342.43433.455370.704336.547296.985396.42335.087305.059276.94838.578393.457262.478187.014273.074133.717127.5490.195130.215108.3891.13471.328103.90864.5568.28145.6770.33240.72643.84438.11544.92345.436
SG&A 634.397-159.9441,039.702448.348570.589376.476745.989392.758467.406235.844697.762303.718451.846205.271695.568289.464427.066-10.412510.422282.201252.708233.926181.641133.721135.617100.474146.44567.629122.81323.201115.47149.06189.53312.58574.58327.11170.48-1.58472.998
Other Expenses 62.4941,039.856-27.657-3.77610.52-9.3274.236-6.968-4.493367.519-165.971186.8988.75346.296-157.793-4.45850.388-4.374-1.161-36.629-1.87811.9370.914.295-0.088-32.9144.838-22.338-0.0570.5110.49-13.61215.24916.0833.9331.0840.801-1.6030.924
Operating Expenses 729.626923.7871,053.254649.95602.143749.444630.654587.917483.533623.891556.594513.577487.616597.788556.075494.771460.318238.209553.252377.795272.104364.783214.17213.657157.381205.076173.823148.063125.841165.236117.35995.16492.508124.81477.74876.76973.61489.26974.946
Operating Income 74.573-90.662-131.33450.31124.58528.63424.88892.68722.223-54.04550.148107.80581.024-181.882-12.606-38.54925.21532.631250.382117.411114.852149.035154.18789.865102.91391.28294.96342.86512.64310.32738.95668.80265.2343.34573.02943.9865.42548.31462.678
Operating Income Ratio 0.037-0.039-0.060.0240.0140.0130.0120.0490.013-0.0280.0250.0560.038-0.09-0.006-0.0190.0130.0160.1190.0860.1090.1250.1460.1130.1310.0970.1160.0640.0210.0150.0630.1220.1350.0860.1640.1090.1770.1230.181
Total Other Income Expenses Net -0.632116.565-145.1880.758-55.021-2.329-0.384-2.347-97.696-103.609-28.715-6.231-77.229-55.415-161.9-82.681-1.879-51.732-87.663-33.272-184.687-7.138-11.971-12.337-25.5264.838-0.2720.3827.7710.469-4.9470.3510.2073.964-2.6210.1432.0597.426
Income Before Tax 73.94125.903-276.52251.17335.10526.30624.50490.3423.317-59.79821.43364.12755.611-136.361-174.505-38.90175.60328.257249.22284.139112.974145.742155.08689.667102.82586.7399.842.59312.5879.83439.42553.55280.47953.55276.99342.68566.00950.37363.602
Income Before Tax Ratio 0.0360.011-0.1270.0240.0190.0120.0120.0480.014-0.0310.0110.0330.026-0.067-0.079-0.0190.040.0140.1180.0620.1070.1220.1470.1130.1310.0920.1220.0630.0210.0140.0640.0950.1670.1070.1730.1050.1790.1280.184
Income Tax Expense 21.02338.384-53.37316.09713.60331.4872.355.4133.679-1.3031.6728.8220.213-29.29112.7061.99710.062-13.87940.8117.64623.3627.59636.03911.63825.846.96625.0878.3454.6570.2767.3668.81113.407-3.22515.1914.03314.63411.2636.576
Net Income 58.721.562-205.57532.76919.823-6.3315.31580.84316.773-58.49515.08852.84130.822-95.422-188.926-46.45255.26833.028190.77274.50580.281113.201110.04175.08275.35375.65372.31433.5324.57410.86831.82245.80467.35558.49861.2329.31251.35639.59156.753
Net Income Ratio 0.0290.001-0.0940.0150.011-0.0030.0070.0430.01-0.030.0080.0270.014-0.047-0.085-0.0230.0290.0160.090.0550.0760.0950.1040.0950.0960.080.0880.050.0070.0160.0520.0820.140.1170.1370.0720.1390.1010.164
EPS 0.10.003-0.360.0570.03-0.0130.0320.170.03-0.120.030.10.06-0.19-0.39-0.0970.150.0730.420.170.180.270.260.180.180.190.230.0870.0120.0260.0770.110.170.190.20.0980.170.130.18
EPS Diluted 0.10.003-0.360.0570.041-0.0130.0320.170.03-0.120.0290.10.06-0.19-0.39-0.0970.150.0730.420.170.180.270.250.180.180.190.230.0870.0120.0260.0770.110.170.190.20.0980.170.130.18
EBITDA 110.84865.724-218.817120.721150.211251.688261.71286.585220.434130.89195.445246.172232.3842.288-35.08511.406201.48152.872268.328143.641150.204158.304175.099124.523116.56199.083120.02453.62217.259-6.72374.52772.80580.12958.21573.78952.17565.86765.18756.176
EBITDA Ratio 0.0540.028-0.10.0570.0830.1110.1240.1510.130.0670.0980.1270.1080.021-0.0160.0060.1070.0260.1270.1060.1420.1330.1650.1570.1480.1050.1460.080.028-0.010.1210.130.1660.1160.1650.1290.1780.1660.162